Results
207 received RT as front-line treatment (68% Indian, 59% male and 32%
received treatment preceding RT outside). Most common diagnosis were
brain tumors (44%), lymphoma (13%). leukemia and soft tissue sarcoma
(10% each). 23.6% had deviation in TTS, 6.0% in TDD and 24.7% in TTC
while 43.4% had at least one deviation in any of these three
parameters. Deviation in TTS varied significantly by location of
preceding treatment and by cancer (greatest deviation in sarcomas) with
issues around access to healthcare the most common reason. Deviation in
TTC varied significantly by cancer (greatest deviation in sarcomas and
medulloblastoma) with myelotoxicity the most common reason.